Canopy Growth Corporation (T:WEED*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Company Contact
Address: 1 Hershey Dr
SMITHS FALLS ON K7A 0A8
Tel: N/A
Website: https://www.canopygrowth.com
IR: See website
<
Key People
Bruce Linton
Chairman of the Board, Chief Executive Officer
Mark Zekulin
President, Co-Chief Executive Officer
Tim Saunders
Chief Financial Officer, Executive Vice President
Rade Kovacevic
Senior Vice President, Managing Director
Olivier Dufourmantelle
Senior Vice President - Strategic Expansion and Continuous Improvement
Mark Ware
Chief Medical Officer
Business Overview
Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.
Financial Overview
For the nine months ended 31 December 2018, Canopy Growth Corp revenues increased from C$55.1M to C$132.3M. Net loss increased from C$8.8M to C$349.8M. Revenues reflect Revenue increase from C$21.7M to C$97.7M, Net revenue increase of 47% to C$49.2M. Higher net loss reflects Share-based compensation expense increase from C$17.7M to C$108.2M (expense), Sales and marketing increase from C$23.5M to C$101.2M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $20,065M as of Dec 31, 2018
Annual revenue (TTM): $155.10M as of Dec 31, 2018
EBITDA (TTM): -$397.73M as of Dec 31, 2018
Net annual income (TTM): -$411.38M as of Dec 31, 2018
Free cash flow (TTM): -$958.22M as of Dec 31, 2018
Net Debt Last Fiscal Year: N/A
Shares outstanding: 343,027,327 as of Jan 28, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization